Kahl Christina R, Means Anthony R
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Biol Chem. 2004 Apr 9;279(15):15411-9. doi: 10.1074/jbc.M312543200. Epub 2004 Jan 30.
The selective inhibitor of the multifunctional calcium/calmodulin-dependent kinases (CaMK), KN-93, arrests a variety of cell types in G(1). However, the biochemical nature of this G(1) arrest point and the physiological target of KN-93 in G(1) remain controversial. Here we show that in WI-38 human diploid fibroblasts KN-93 reversibly arrested cells in late G(1) prior to detectable cyclin-dependent kinase 4 (cdk4) activation. At the KN-93 arrest point, we found that cyclin D1/cdk4 complexes had assembled with p21/p27, accumulated in the nucleus, and become phosphorylated on Thr-172, yet were relatively inactive. Additional examination of cdk4 complexes by gel filtration analysis demonstrated that, in late G(1), cyclin D1-containing complexes migrated toward lower molecular weight (M(r)) fractions and this altered migration was accompanied by the appearance of two peaks of cdk4 activity, at 150-200 and 70 kDa, respectively. KN-93 prevented both the activation of cdk4, and this shift in cyclin D1 migration and overexpression of cyclin D1/cdk4 overcame the KN-93 arrest. To determine which multifunctional CaMK acts in G(1), we expressed kinase-deficient forms of CaMKI and CaMKII. Overexpression of kinase-deficient CaMKI, but not CaMKII, prevented cdk4 activation, mimicking the KN-93 arrest point. Therefore, we hypothesize that KN-93 prevents a very late, uncharacterized step in cyclin D/cdk4 activation that involves CaMKI and follows complex assembly, nuclear entry, and phosphorylation.
多功能钙/钙调蛋白依赖性激酶(CaMK)的选择性抑制剂KN-93可使多种细胞类型停滞于G1期。然而,这种G1期停滞点的生化本质以及KN-93在G1期的生理靶点仍存在争议。在此我们表明,在WI-38人二倍体成纤维细胞中,KN-93可使细胞在可检测到的细胞周期蛋白依赖性激酶4(cdk4)激活之前可逆地停滞于G1晚期。在KN-93停滞点,我们发现细胞周期蛋白D1/cdk4复合物已与p21/p27组装,在细胞核中积累,并在苏氨酸172处发生磷酸化,但活性相对较低。通过凝胶过滤分析对cdk4复合物进行的进一步检测表明,在G1晚期,含细胞周期蛋白D1的复合物向较低分子量(M(r))组分迁移,这种迁移变化伴随着分别在150 - 200 kDa和70 kDa处出现的两个cdk4活性峰。KN-93可阻止cdk4的激活,并且细胞周期蛋白D1迁移的这种变化以及细胞周期蛋白D1/cdk4的过表达可克服KN-93的停滞作用。为了确定哪种多功能CaMK在G1期起作用,我们表达了CaMKI和CaMKII的激酶缺陷形式。激酶缺陷型CaMKI的过表达而非CaMKII的过表达可阻止cdk4激活,模拟了KN-93停滞点。因此,我们推测KN-93阻止了细胞周期蛋白D/cdk4激活中一个非常晚期且未明确的步骤,该步骤涉及CaMKI且发生在复合物组装、进入细胞核和磷酸化之后。